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Summary Numerous methods have been proposed for the detection of hypoxic cells using nitroimidazoles
labelled with both radioactive and stable isotopes where the isotopic label becomes bound as a result of
reductive metabolism of the nitro group. A new probe for hypoxia, 7-(4'-(2-nitroimidazol-1-yl)-butyl)-theo-
phylline, is described where an immunologically recognisable hapten (theophylline) is covalently linked to a
2-nitroimidazole. Bioreduction of the nitroimidazole leads to binding of bioreductive metabolites, and hence
the theophylline side-chain, to intracellular molecules. Immunochemical procedures are then used to stain cells
containing the bound theophylline using an FITC-conjugated anti-serum. Flow cytometric analysis of stained
cells is facilitated by co-staining cellular DNA, which allows discrimination of single cells in the sample and
rejection of cell clumps and debris. The alternative use of an immunoperoxidase-conjugated anti-serum has
been used to demonstrate the localisation of hypoxic cells in frozen tumour sections.
The existence of poorly oxygenated radioresistant cells in
tumours is thought to be one of the factors contributing to
local failure of radiotherapy and tumour regrowth (Gray et
al., 1953; Churchill-Davidson et al., 1966; Bush et al., 1978;
Mueller-Klieser et al., 1981; Dische, 1985; Dische et al., 1986;
Overgaard et al., 1986). A simple, rapid clinical test for the
presence of hypoxic cells in tumours could enable radio-
therapy to be optimised for individual patients on the basis
of the oxygen status of their tumours. Adjuncts to radio-
therapy such as hypoxic cell sensitisers and hyperbaric or
normobaric oxygen could then be administered to those
patients most likely to benefit from them.
Of the methods that have been proposed for determining
the hypoxic fractions of tumours, several are based on the
hypoxia-dependent bioreductive metabolism of a labelled 2-
nitroimidazole which results in binding of labelled fragments
of the original compound to cellular macromolecules.
Various labels have been proposed, including 3H (Raleigh et
al., 1985), 14C (Chapman et al., 1981; Franko & Chapman,
1982; Garrecht & Chapman, 1983), 75Br, 76Br, 7Br (Rasey et
al., 1985) and '9F (Raleigh et al., 1986): 3H-misonidazole has
been administered to small numbers of patients with treat-
ment-resistant tumours (Urtasun et al., 1986). Identification
of hypoxic cells using radiolabelling requires prolonged auto-
radiography to detect labelled regions of tumour sections.
NMR detection of bioreductively bound metabolites of fluor-
inated nitroimidazoles in tissues has been demonstrated
experimentally and such bound metabolites have also been
detected by fluorescence immunohistochemistry (Raleigh et
al., 1987).
In this paper, we describe the use of the immunologically
detectable hapten theophylline, covalently bound to a 2-
nitroimidazole, as a method of identifying hypoxic cells. An
isotopic label on the side-chain of misonidazole binds to
cellular constituents as efficiently as a ring label (Raleigh et
al., 1985) and an immunologically recognised side-chain
should behave similarly. Data are presented showing that this
approach enables hypoxic cells to be identified both in vitro
and in solid tumours in vivo.
Materials and methods
Chemicals
Synthesis of 7-(4'-(2-nitroimidazole-1-yl)-butyl)-theophylline
(NITP) will be described elsewhere. Cremophor, peanut oil,
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propidium iodide, RNAase and all anti-sera were obtained
from Sigma Chemical Company. Dimethyl sulphoxide
(DMSO) and other reagents were BDH AnalaR grade. Spec-
ial gases (air + 5% C02, oxygen + 5% C02, nitrogen + 5%
C02), were obtained from British Oxygen Company. Other
gas mixtures containing a range of oxygen tensions were
prepared by volumetric mixing of air + 5% CO2 and nitro-
gen + 5% CO2 into empty gas cylinders. All special gas
mixtures were checked with a Thermox oxygen meter.
In vitro studies
V79 379A Chinese hamster cells were maintained as exponen-
tially growing suspension cultures in Eagle's Minimal Essen-
tial Medium with Earle's salts, modified for suspension
culture, with 7.5% foetal calf serum. Cell suspensions (5 x
105 cells ml-') were stirred under air + 5% CO2 or nitrogen
+ 5% CO2 and incubated with drugs at 37°C as previously
described (Begg et al., 1985; Hodgkiss et al., 1987). Because
of the poor water solubility of NITP it was initially dissolved
at 10-50 mmol dm-3 in DMSO and small volumes added to
cell suspensions in growth medium to give the appropriate
dug concentration. The final concentration of DMSO was
1% or less. Following incubation with NITP cells were
washed with phosphate buffered saline (PBS) and suspended
in 2 ml of PBS before fixation with 20 ml 70% ethanol.
Toxicity measurements were carried out under identical con-
ditions and survival assessed in a 7-day colony forming
assay.
In vivo studies
(a) Tumours The carcinoma CaNT and sarcoma SaF used
in this study are a moderately differentiated mammary car-
cinoma and an anaplastic sarcoma of spontaneous origin,
respectively, which are maintained by serial passage in CBA
mice. The carcinoma Rh is a moderately well differentiated
adenocarcinoma of spontaneous origin (Hill et al., 1989)
which is maintained by serial passage in WH mice. Tumours
were implanted as dorsal subcutaneous tumours in male mice
and were used at a mean diameter of 10 mm calculated from
three orthogonal measurements
(b) Drug administration Administration of NITP (0.5tLmol
g9i) was by intra-peritoneal injection of the drug in peanut
oil containing 10% DMSO; the total volume injected was
0.38 ml for a 35 g mouse. In the case of animals carrying Rh
and SaF tumours the drug was suspended in cremophor
containing 10% ethanol. Some animals were made to breathe
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carbogen (95% oxygen + 5% C02), following administration
of the drug, by placing them in small plastic boxes (18 x
18 x 13 cm) through which carbogen was passed at I I min-
following an initial 5 min flushing at (51 min-').
(c) Tissue preparation Animals were killed by cervical dis-
location 2 h after administration of the drug, and tumours
were rapidly removed and minced finely with scissors. A cell
suspension was made by repeated pipetting of the fragments
suspended in PBS using a 5 ml automatic pipette. The result-
ing suspension was filtered through 35 im nylon mesh
(Lockertex, Warrington, Cheshire), centrifuged at 300g and
the cell pellet resuspended in 2 ml PBS before fixation in
20 ml 70% ethanol. Once fixed in 70% ethanol, cell suspen-
sions could be stored at 4°C for several weeks, if required,
before staining.
For preparation of frozen tumour sections, freshly excised
CaNT tumours were snap-frozen in liquid nitrogen. Frozen
sections were cut on a cryostat at 4 lm thickness and stored
at -70°C until required.
Immunochemical staining
To stain for bound theophylline groups, 2 x 106 fixed cells
were washed in PBS, and suspended in 1 ml PBS containing
0.5% Tween-20 and 0.1% normal goat serum for 15 min to
reduce non-specific antibody binding sites; during optimisa-
tion of the staining protocol it was found that higher concen-
trations of goat serum reduced the specificity of binding of
the antiserum. (The concentrations of first and second anti-
bodies were also optimised for this application.) The cells
were then centrifuged, resuspended in 0.25 ml polyclonal rab-
bit antiserum raised against theophylline and incubated for
1 h at 20C. Following this incubation, the cells were washed
and resuspended in 0.5 ml PBS containing 10 l of affinity-
isolated goat anti-rabbit IgG FITC conjugate and incubated
for I h at 20°C. The cells were then washed and suspended in
2 ml PBS for analysis. For DNA staining, cells were treated
with I mg ml-' RNAase and propidium iodide (I5pmol dm-3) added.
Before immunoperoxidase staining for bound theophylline,
frozen sections were air-dried and fixed in cold acetone
(4°C, 10 min'). Endogenous peroxidase was blocked by incu-
bating samples for 15 min at room temperature in PBS
containing 0.03% hydrogen peroxide and sodium azide
(I5 mmol dm-3). Non-specific staining was blocked by pre-
incubating sections with 0.1% normal goat serum. A 0.1%
polyclonal rabbit anti-serum against theophylline was applied
and the sections incubated for I h. After washing in PBS, a
goat anti-rabbit IgG-horseradish peroxidase conjugate was
applied at a dilution of 1:50 and incubated for I h. Sections
were washed in PBS and incubated with diaminobenzidine
HCI solution (2 mmol dm-3) containing imidazole (I mmol
dm-3) and hydrogen peroxide (0.006%) for a further 5 min
to develop the insoluble peroxidase reaction product. Sec-
tions were lightly counterstained with haematoxylin before
dehydrating and mounting.
Flow cytometry
Analysis of cells was carried out on an Ortho Systems 50
cytofluorograph using excitation at 488 nm by a Coherent
5 W laser operating at 200 mW, and collection of fluorescent
emission at 900 to the incident beam. Following passage
through a dichroic lens to deflect scattered excitation wave-
lengths, the fluorescent emission from the FITC-conjugated
antiserum was collected at wavelengths between 510 and
560nm using a short band-pass filter and red fluorescence
from propidium iodide, if present, above 620 nm. Cell
doublets, clumps and debris were excluded by gating on the
red fluorescence peak vs area histogram. Forward scattered
light at the excitation wavelength was also collected and used
to discriminate non-cellular debris (low scatter) in some
experiments. At least 10,000 single cells were analysed from
each sample. To estimate tumour hypoxic fractions, the limits
ofnon-specific green staining had to be defined. A region was
set on the green (FITC) vs red (propidium iodide) fluores-
cence histogram for stained cells from control tumours from
mice that did not receive the injection of NITP so that the
majority (e.g. >99%) of cells were excluded from the region because their green fluorescence was too low. The proportion
of stained cells, from tumours exposed to NITP within this
gated region was then taken as a measure of the hypoxic fraction. Cell cycle analysis was also carried out by setting
appropriate regions according to DNA content on the same
cytograms with the same region used to discriminate oxic and
hypoxic cells.
Photomicroscopy
Histological slides were observed using a Nikon Optiphot
microscope and photographed on Kodak Ektachrome (ASA
100) daylight colour slide film.
(d) Pharmacokinetics Plasma and tumour concentrations of
NITP were determined by HPLC. Blood samples were taken
in heparin and the plasma separated by centrifugation.
Tumours were removed, frozen in liquid nitrogen and stored
with the plasma at - 20°C prior to analysis. To 0.1 ml
plasma was added 25 nmol benznidazole internal standard
(Roche Products Ltd) and 2 ml methanol. Tumours were
weighed into a tube containing 25 nmol benznidazole, 0.4 ml
ice cold water was added, and the sample homogenised.
Methanol (2ml) was added and plasma and tumour extracts
were then centrifuged and the supernatant taken to dryness.
Samples were then reconstituted in 0.2 ml HPLC eluent (28%
acetonitrile; 72% water) and an aliquot injected onto the
HPLC (Waters 840) using a hypersil 5ODS column
(12.5 cm x 4.6mm) (Hichrom Ltd) with a Waters 441 detec-
tor using the 340 nm filter. Flow rate was 2 ml min-'.
(e) Physiology Rectal temperature measurements were car-
ried out on control and drug-treated tumour-bearing animals
using a calibrated platinum thermometer. Breathing rate
measurements were also carried out on tumour-bearing
animals before and after drug administration using an air-
tight whole body plethysmograph (Travis et al., 1979). Rela-
tive blood flow was assessed in tumours and gastrocnemius
muscle by measuring 86RbCl uptake (Sapirstein, 1958).
Animals were killed by cervical dislocation 90 s after admin-
istration of the radioactive tracer and tumours and muscle
rapidly removed. The 86Rb content of the samples was
measured in a Wallac 1282 gamma counter.
Results
In vitro studies
Following incubation of V79 Chinese hamster cells with
NITP (0.1 mmol dm-3), immunochemical fluorescent staining
procedures for theophylline demonstrated more products of
drug metabolism to be bound to cells incubated in hypoxic
conditions compared with aerobic conditions (Figure la). Unbound parent drug is effectively removed during sample preparation and cannot be detected by HPLC in washed
cells. The time course of metabolic binding of the theophyl- line side-chain to cells incubated under oxic and. hypoxic
conditions is shown in Figure lb; a maximum hypoxic:oxic
differential of fluorescent staining was obtained after 3-4 h
incubation. The level of non-specific staining obtained with
cells that had not been exposed to the drug was the same as
that at the zero time point where exposure was brief
(< I min) and under aerobic conditions, metabolic binding
increased only slightly. Exposure of cells to free theophylline
(0.4 mmol dm-3) under aerobic and hypoxic conditions had
no effect on the level of non-specific staining. The hypoxic
toxicity of the drug is not substantially greater than that of
misonidazole (Figure 2); the concentration of NITP at which
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Figure 1 a, Distribution of fluorescent staining for bound theo-
phylline in oxic (unshaded area) and hypoxic cells (shaded area).
Bars indicate the 95% population confidence limits. b, Time
course of metabolites of 0.1 mmol dm-3 NITP binding to V79
Chinese hamster cells at 37°C, detected by fluorescent immuno-
histochemistry: (0) hypoxic cells; (0) oxic cells. Each point
represents the mean and standard error of three replicate deter-
minations.
drug during a 7-day colony-forming assay under aerobic
conditions is 0.7mmoldm-3 compared with 1.3 mmol dm-3
for misonidazole.
The hypoxic:oxic differential in fluorescent staining is
observed over a wide range of extra-cellular NITP concentra-
tions in vitro (Figure 3a). When cells were incubated with
NITP (0.1 mmol dm 3) under a range of oxygen concentra-
tions the value for half the hypoxic:oxic differential of meta-
bolic binding was found to be 1,400 ppm (Figure 3b), which
is similar to the value of 3,800 ppm for half of the oxygen
radiosensitising effect, determined under identical conditions
(Begg et al., 1985).
In vivo studies
Physiological measurements of tumour-bearing animals show
that NITP, when injected at 0.5timol g- I in peanut oil
(Figure 4) has only a small effect on rectal temperature and
little effect on breathing rate. There was also no significant
effect of the drug on tumour or muscle blood flow 50 min
after injection (Table I). NITP appeared to be well tolerated
and no deaths occurred in ten animals observed for 24 h
following drug administration.
Bound theophylline groups could be readily detected
immunochemically in mouse tumours within 45-60 min fol-
lowing treatment in vivo with NITP (Figure Sa), rising to a
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Figure 2 Hypoxic toxicity of NITP to cells: (0) 0.5 mmol dm-3;
(A) 1.0 mmol dm 3; (0) 2.0 mmol dm '. (A) oxic toxicity of
2 mmol dm- NITP. Hypoxic toxicity survival curves for miso-
nidazole under identical conditions: ( ) 3 mmol dm 3; (-- )
5 mmol dm 3 from Hodgkiss and Middleton (1985). At 0.1 mmol
dm-3 NITP was not toxic in oxic or hypoxic conditions during
8 h incubation. Standard errors are smaller than the sizes of the
points plotted.
maximum value after 2 h. HPLC measurements of NITP in
plasma show that the drug, when injected at 0.5ltmol g-' in
peanut oil, rapidly reaches a maximum plasma concentration
of 100 nmol ml-' (Figure 5b) which is sustained for a period
of about I h; the plasma drug level subsequently falls with a
half life of 32 min in mouse tumour and plasma. The parent
drug can be detected in the tumours by HPLC before bound
adducts can be detected immunologically; the delay before
the appearance of bound adducts must reflect the time
required for bioreductive metabolism to occur.
More bound theophylline groups were detected in cells
from all tumours treated with NITP in air-breathing mice
than in carbogen breathing mice (e.g. Figure 6). However,
some high fluorescence was also observed when cells from
control tumours not treated with the drug were stained for
theophylline groups. This high control fluorescence resulted
from two or more cells clumping together; it could be greatly
reduced by staining DNA with propidium iodide and gating
on the red fluorescence peak vs area signal to eliminate all
particles except single cells (e.g. Figure 7). Single cell disc-
rimination is achieved by this method because the width of
the signal generated by a fluorescent particle in the flow
cytometer is the sum of the beam width and the particle
diameter. A comparison of signal area and peak separates
the single cells from clumps because the increase in nuclear
diameter is much greater for two or more G1 cells stuck
together than occurs over the cell cycle, (Ormerod, 1989). The
diploid GI normal host cell population can be seen at about
channel 15, the GI aneuploid tumour cells at channel 30 and
the G2 aneuploid cells at channel 60. There may be a small
contamination of the GI aneuploid cells with G2 diploid
cells. Analysis of the histograms based only on single cells
showed the levels of hypoxia in Table I1; more hypoxic cells
were found in tumours from animals breathing air compared
with carbogen, and less staining was observed in control
animals not treated with -the drug. Work in progress suggests
that similar levels of hypoxia occur in other CaNT tumours
and that the reduction in tumour hypoxia observed when
mice breathe carbogen correlates well with changes in the
sensitivity of the tumours to fractionated radiation (Rojas et
al., 1990). The animals with Rh and SaF tumours were
injected with NITP suspended in cremophor; similar levels of
121staining are seen in CaNT tumours when NITP is suspended
in either peanut oil or cremophor (data not shown).
Immunoperoxidase staining of frozen sections of CaNT
tumours showed that bound metabolites of NITP occurred
mainly at the edges of tumour cords (Figure 8). Little
immunoperoxidase staining was found in most tumour cords
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Figure 4 a, Measurements of rectal temperature in tumour-
bearing animals: (0) untreated animals; (0)0.5 Lmol g- NITP
injected i.p. in peanut oil at t = 0 min. b, Measurements of
breathing rate in tumour-bearing animals. (0) untreated animals;
(0) 0.5 ymol g-' NITP injected i.p. in peanut oil at t = 0 min.
Each point represents the mean and standard error of five
separate determinations.
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Figure 3 a, The dependence of NITP metabolites binding to
cells on extracellular concentration: (0) hypoxic cells; (0) oxic
cells. b, The oxygen-dependence of NITP metabolites binding to
V79 Chinese hamster cells at 37°C, detected by fluorescent
immunohistochemistry. Each point represents the mean and error
of three independent determinations. Vertical lines indicate the
values for half the hypoxic:oxic differential of metabolic binding
(1) and half of the oxygen radiosensitising effect (2), determined
under identical conditions (from Begg et al., 1985).
Table I Mean relative blood flow measurements and standard errors in
CaNT tumours and gastrocnemius muscle in five untreated animals and
five animals treated with 0.5tLmol g-' NITP injected i.p. in peanut oil
% injected 86Rb activityg-'
Tumour Muscle
Control 1.17±0.07 2.74±0.24
NITP 1.29±0.23 2.43±0.21
E -a
E
z Table II Analysis of flow cytometric histograms of cell suspensions
prepared from mouse tumours using data for single cells discriminated
on the basis of DNA staining
% Highfluorescence
Treatment Rh CaNT SaF
Air 21% 02 29.1 ± 1.9 (2) 22.9±2.3 (9) 18.8 (1)
Carbogen 95% 02 8.0 (1) 3.8±1.6 (4) 10.0 (1)
Control No drug 0.5±0.1 (2) 1.6±0.7 (7) 0.6 (1)
Number in brackets represents the number of tumours contributing
to each mean and standard error.
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Figure 5 a, Time course of NITP binding to CaNT tumour cells
in vivo. b, (0) plasma and (0) tumour concentrations of NITP
measured in the same animals. The plasma half-life (32 min) was
determined over the period indicated by the solid line. Each point
represents the mean and standard error of three separate deter-
minations.
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Figure 6 Typical flow cytometric analysis of mouse CaNT
tumour cells treated in vivo with NITP, following green fluores-
cent immunohistochemical staining. The vertical axes represent
cell numbers. a, control tumour, no drug exposure; b, air-breath-
ing mouse: c, carbogen-breathing mouse.
within 5-6 cell diameters of the central blood vessels, or in
the necrotic material surrounding the tumour cords. Occa-
sionally, however, a tumour cord was found in which
immunoperoxidase staining occurred adjacent to the blood
vessel and throughout that particular cord (Figure 8, lower
right). Such heavily stained tumour cords may represent
regions that became acutely hypoxic by blood-vessel occ-
lusion at a time when the probe had already diffused into the
tumour.
Discussion
Numerous studies have demonstrated the hypoxia-specific
binding of isotopically labelled 2-nitroimidazoles to cellular
components and it has been possible to develop an immuno-
histochemical method for detecting bound metabolites of a
fluorinated nitroimidazole (Raleigh et al., 1987). We have
used a commercial antiserum to theophylline to quantify
similarly bound metabolites of a 2-nitroimidazole with a
theophylline side-chain. In vitro studies have shown bioreduc-
tive binding of NITP to be highly hypoxia-specific and to
have a similar oxygen-dependence to radiosensitivity. While
there may be a small overlap between the range of intensities
of fluorescent staining seen with pure oxic and hypoxic cell
populations, the mean fluorescence of the two groups is well
separated. Metabolic binding of NITP to hypoxic cells can be
readily demonstrated under conditions where there is no
toxicity. With long incubation times, a plateau is observed in
the amount of bound drug detectable in cells, although the
cells are still completely viable. We have observed similar
binding curves with other nitro-aromatic compounds tested
as fluorescent probes for hypoxic cells, under identical condi-
tions (e.g. Begg et al., 1985); the apparent plateau in drug
binding may reflect further metabolism of bound adducts to
t100 non-recognisable forms.
The drug is tolerated well in vivo with little effect observed
on body temperature, breathing rate or relative tumour and
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Figure 7 Typical flow cytometric contour plots of DNA staining
vs green fluorescent immunohistochemical staining for theophyl-
line of mouse CaNT tumour cells treated in vivo with NITP. a,
control tumour, no drug exposure: b, air-breathing mouse: c,
carbogen-breathing mouse. The regions used to generate the high
green fluorescence data in Table II are indicated. The inset shows
the DNA distribution as a histogram of cell number vs DNA
content for this tumour.
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Figure 8 Immunoperoxidase staining for bound theophylline of
frozen sections of the CaNT mouse mammary carcinoma treated
in vivo with NITP. The bar represent 0.2 mm.
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Figure 9 The structure of 7-(4'-(2-nitroimidazol-1-yl)-butyl)-theo-
phylline (NITP).
muscle blood flow. The maximum plasma levels obtained in
vivo following administration of NITP (0.5 ILmol g-') in pea-
nut oil are well below the concentrations at which any
hypoxic or oxic toxicity can be detected in vitro. The long
plateau observed in the concentration of NITP in the plasma
suggests that this method of drug administration may result
in slow sustained release of the drug, thereby achieving a
significant tumour concentration for sufficient time for bio-
reductive metabolism to occur. The extracellular NITP con-
centration-dependence of hypoxic-oxic differential staining
observed in vitro suggests that it may be possible to use
smaller amounts of NITP in vivo, although in practice it has
been found that reducing the amount of NITP administered
reduces the differential between the highest levels of staining
and the non-specific background staining.
Bound adducts can also be readily demonstrated in cells
from all tumours treated in vivo with this compound. Fur-
thermore, the large reduction in binding observed when the
animals breathe carbogen suggests that we are observing a
real cell population where the oxygen supply is normally
restricted. A similar reduction in tumour hypoxia when mice,
adapted to breathing 10% oxygen, breathe carbogen has
been shown to reduce the amount of labelled misonidazole
binding to tumour cells (Franko, 1986). Radiobiological
studies have estimated mean hypoxic fractions of 30% (95%
confidence interval 14-62%) for the Rh tumour, 38% (95%
confidence interval 26-55%) for the CaNT tumour and 69%
(95% confidence interval 42-100%) for the SaF tumour in
animals breathing air (Moulder & Rockwell, 1984). While
similar hypoxic fractions to the radiobiological mean values
are derived here from the flow cytometry data (Table II), a
direct comparison cannot be made as the estimates of radio-
biological hypoxia are not contemporary and some changes
in tumour growth characteristics have been noted since these
estimates were made (e.g. Anderson et al., 1989). Although
similar hypoxic fractions have been estimated from measure-
ments of xanthine oxidase and xanthine dehydrogenase
(Anderson et al., 1989), these estimates also require
radiobiological calibration.
Experiments carried out in vitro suggest that NITP will
slightly underestimate the degree of hypoxia, compared with
the radiobiological effects, so that those cells that are detect-
ed are likely to be sufficiently deprived of oxygen to be
radioresistant. The precision with which NITP detects small
proportions of cells with intermediate levels of oxygen is
limited by the non-specific background staining, but the
mean fluorescence of completely hypoxic cells should be well
separated from that of completely oxic cells. In practice the
continuous distribution of oxygen tensions expected within
tumours results in a continuous distribution of staining inten-
sities, making fine distinctions of oxygen levels difficult. We
have shown that the changes in hypoxic fraction measured
using NITP correlate well with changes in tumour radiosen-
sitivity in animals breathing air, carbogen or oxygen at the
time of treatment (Rojas et al., 1990).
It has been shown that much of the bioreductive binding
of misonidazole is to acid-soluble components of the cell
such as glutathione (Miller et al., 1982; Smith & Born, 1984);
if NITP metabolites behaved similarly, fixation and permeab-
lisation of the cells would presumably extract such low
molecular weight conjugates. However, the immunochemical
procedures employed here are sensitive enough to detect the
remaining adducts to high molecular weight components of
the cell. Although it has been reported that 90% (Miller et
al., 1982) and 41% (Smith, 1984; Smith & Born, 1984) of the
total 14C and 3H-labelled misonidazole binding to the macro-
molecular fraction of cells is associated with the RNA, 80%
of the staining for bound adducts of NITP is obtained in
cells treated with RNAase to enable specific staining of the
DNA with propidium iodide. The improved flow cytometric
analysis of the cell suspension (based on discrimination of
single cells) that can be carried out following staining of the
DNA compensates for the small reduction in the amount of
staining for the hypoxia marker resulting from the removal
of RNA. Almost all of the highly fluorescent particles found
when cell suspensions from tumours which have not been
exposed to NITP are stained for bound theophylline are
non-cellular debris or clumps of one or more cells, and can
be identified and excluded from analysis on the basis of
DNA content. DNA staining also allows the distribution of
hypoxic cells throughout the cell cycle to be studied;
preliminary data suggest that hypoxia is found throughout
the cell cycle among the aneuploid tumour cells, but that
lower levels of hypoxia may be found in the Gl diploid
normal host cells. Alternative second staining procedures
may also allow tumour hypoxia to be correlated with other
parameters such as labelling index, markers for specific cell
types and thiol status.
In frozen sections of the CaNT tumour stained for the
presence of bound probe metabolites, immunoperoxidase
staining is found in the histologically intact cells at the
periphery of tumour cords where oxygen tensions would be
expected to be low (Gray et al., 1953; Thomlinson & Gray,
1955). As necrotic regions of the tumour are not markedly
stained, the flow cytometric measurements of tumour hypo-
xia exclude the necrotic material which is unlikely to
influence the efficacy of treatment. Similar distributions of
staining were observed by Raleigh et al. (1987) in the Walker
carcinoma using immunofluorescent detection of metabolites
of a fluorinated nitroimidazole, although their stain appears
to stain tumour necrosis as well as several layers of healthy
cells adjacent to the necrotic regions. Occasionally tumour
cords are seen where the immunoperoxidase staining is adja-
cent to the blood vessels. This may represent an example of
acute hypoxia where the blood flow has become temporarily
disrupted at a time when the probe was available in the
tumour cells for bioreductive metabolism.
Fluorescent immunochemical staining of bound metabo-
lites of NITP in cell suspensions, followed by flow cytometric
analysis provides a rapid, convenient assay for the hypoxic
fraction in solid tumours in vivo with considerable potential
in the investigation of experimental radiotherapy in animal
models (Rojas et al., 1990). While further development work
is still required, these early results illustrate that immuno-FLOW CYTOMETRIC EVALUATION OF HYPOXIC CELLS IN TUMOURS 125
chemical detection of bound metabolites of suitable nitro-
aromatic compounds could provide the basis for a simple test
to estimate the hypoxic fraction in clinical tumour samples.
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